Press the l key to open the language menu.
Skip Main Navigation and go to Content

Our mission is to develop visual prosthetics to enable blind individuals to see.

Management

Will McGuire - President and CEO

Mr. McGuire joined Second Sight in August 2015 as President and CEO.  Most recently he was with Volcano Corporation, where he was President of Americas Commercial since 2014 and prior to that, Senior Vice President and General Manager of Coronary Imaging, Systems and Program Management since 2013. Prior to that Mr. McGuire served as Vice President and General Manager of Patient Monitoring at Covidien. He previously served as President and Chief Executive Officer of AtheroMed, Inc., a venture capital-backed peripheral atherectomy company, prior to which he was Chief Operating Officer at Spectranetics Corporation, a publicly-traded medical device company. In addition, Mr. McGuire held various positions at Guidant Corporation from 1998 to 2005 including General Manager of Guidant Latin America; Director of U.S. Marketing for Vascular Intervention (VI); Director of Global Marketing for VI; and, Production Manager for Coronary Stents. Prior to 1998, Mr. McGuire held positions in Finance and Production at IVAC Medical Systems. A graduate of the Georgia Institute of Technology, Mr. McGuire received his M.B.A. from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill.

 

John Blake – Chief Financial Officer

Mr. Blake most recently served as Senior Vice President, Finance of aTyr Pharma, a publicly-traded biotechnology company he joined in March 2015. Prior to aTyr, Mr. Blake was responsible for the global financial planning and analysis function at Volcano Corporation (Volcano), a publicly-traded medical device company, where he successfully executed Volcano's rapid growth and expansion as Director, Financial Planning and Analysis from March 2010 to March 2015 and as the SEC Reporting Manager from November 2008 through March 2010. Mr. Blake was also previously an auditor in public accounting and an analyst for BD Biosciences. His extensive transactional experience spans multiple public offerings and mergers and acquisitions, including the $1.2 billion sale of Volcano to Royal Philips, NV in February 2015. Mr. Blake is a Certified Public Accountant, holds a Bachelor of Business Administration from National University and is a Beta Gamma Sigma scholar at Marshall School of Business at the University of Southern California. Mr. Blake has completed leadership executive education at Harvard Business School and the Strategic Financial Leadership Program at Stanford Graduate School of Business.

 

David Jacques – Vice President of Research & Development

Mr. Jacques joined Second Sight in February 2017. From 2012 through 2016 he was a principal of his management consulting firm where his clients included various high tech companies including Second Sight Medical Products, Inc. His duties and responsibilities included analyzing existing and leading edge technologies, aiding in assembly of world class engineering teams, working with management to devise innovative systems and continuous improvement of enterprise systems, and managing multiple complex projects. From 2012 to 2014 Mr. Jacques also was founder and Chief Technology Officer of AcuteTeleCare, LLC, a developer of a next generation, state of the art telemedicine platform to facilitate rapid diagnosis and treatment for patients with acute conditions, such as cerebral stroke. From 2006 to 2012 Mr. Jacques also served as Vice President, Research & Development at Stereotaxis, Inc. where he was the company leader of all engineering teams specializing in organizational evaluation, role identification and structural effectiveness for a high-tech leading edge medical manufacturer. He earned a Bachelor of Science, Electrical Engineering degree from the University of Arizona.

 

Amit Kukreja - Vice President, Global Reimbursement & Market Access

Mr. Kukreja is our Vice President, Global Reimbursement & Market Access since October 2016. He joined Second Sight in January 2012 as Director of Market Access, EMEA and successfully expanded reimbursement approvals in some of the key European markets. Between 2007 to 2011, Mr. Kukreja worked as Market Access Consultant where he formulated and executed reimbursement & pricing strategy for several innovative medical devices. As Consultant, he held positions of increasing responsibility at Synergus MedTech Consulting, Sweden (as Associate Director, Project Leader and Project Manager- Global Market Access), Simon-Kucher & Partners, Germany (as Pricing Strategy Consultant) and as a Freelancer. From 2014-2016, he was a member of Eucomed Ophthalmology Group and also led the European MedTech Reimbursement Program at RAPS, Switzerland Chapter. From 2005 to 2007, Mr. Kukreja worked as Sales Representative for Godrej & Boyce, India. Amit holds a Bachelor of Mechanical Engineering from Manipal University, India and an MBA from WHU–Otto Beisheim School of Management, Germany including management modules from Kellogg School of Management, USA, CEIBS, China and IIM Bangalore, India.

 

Steve Okland  Commercial Vice President, U.S. and Canada

Mr. Okland joined Second Sight in March 2016 as Commercial Vice President, U.S. and Canada.  Most recently he was president of Sanford Rose Associates – Okland Group, Inc., which specialized in commercial executive talent acquisition for early stage to mid-cap medical device companies. Previously, he served as Vice President, Worldwide Marketing and Sales, at Miramar Labs, Inc., a medical device company targeting dermatologic medical conditions, where he led all commercialization activities. Prior to that, Mr. Okland served as Vice President, Worldwide Marketing and U.S. Sales at Medivance, Inc., and directed the turnaround of all commercialization activities resulting in a $250M acquisition by Bard Medical. At Spectranetics, Inc., as Vice President, U.S. Sales and Marketing, he directed all U.S. sales and marketing operations during a period when the company was named to Fortune’s 100 Fastest Growing Companies three years in a row. He also held several sales positions of increasing responsibility during 12 years at Boston Scientific Corporation and at Johnson & Johnson Medical, Inc., where he began his career. He earned a Bachelor of Science degree from the University of Wisconsin and a Masters of Business Administration from Texas Christian University.

 

Edward Randolph – Vice President of Operations, Quality and IT

Mr. Randolph served as Vice President of Manufacturing from 2007 to 2016. From 2003 to 2007, he was Director of Manufacturing Engineering at the electrophysiology division of Boston Scientific Corp, where he was instrumental in the execution of remedial process validation in response to their 2006 FDA Warning Letter. From 2001 to 2003, Mr. Randolph was the Director of Manufacturing Engineering at Cygnus, Inc., a manufacturer of novel non-invasive transdermal drug delivery systems. Prior positions included 7 years at Ventritex, an implantable cardiac defibrillator company where he facilitated the relocation of manufacturing following the acquisition of that company by Pacesetter. He received his Master of Science in Engineering from Stanford University and his Bachelor of Science in Architecture from Massachusetts Institute of Technology.

 

Frank Vandeputte – Vice President and General Manager EMEA and Asia Pacific

Mr. Vandeputte was appointed Vice President and General Manager EMEA and Asia Pacific in October 2017. Most recently as a consultant, Mr. Vandeputte served as Vice President of Global Sales for Occlutech AB, as a board member of AuXin Surgery, as well as serving in other sales and marketing roles for several medical device companies such as Trivascular Inc., Aptus Endosystems and EBR systems. Between December 2009 and April 2011, Mr. Vandeputte was Vice President Sales and Marketing for Oxford Immunotec, and between July 2008 and July 2009, he served as Vice President Europe for CryoCath Technologies. Mr. Vandeputte has a bachelor degree in Physiotherapy from SHIPMB Gent and a postgraduate degree in Business Administration from the Flemish Business School, VLEKHO in Brussels.